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Preincubation of human platelet membranes with the ATP analog ATP[yS] led to persistent adenylate cyclase activation. 
This stimulation was increased by copreincubation with PGE, and obliterated by removing endogenous GDP by the 
NTP-regenerating system, creatine phosphate plus creatine kinase. PGE, partially reversed the action of the regenerating 
system. Control formation of GTP[yS] from ATP[yS] and GDP in platelet membranes was apparently not stimulated 
by PGE,. In contrast, in the presence of creatine phosphate plus creatine kinase, which prevented formation of GTP[yS], 
PGE, stimulated formation of this GTP analog, by partially reversing the action of the NTP-regenerating system. The 
data indicate that GTP[yS] can be formed by a membrane-associated nucleoside diphosphokinase from ATP[yS] and 
GDP, resulting in persistent G,-protein activation, and that this process can be stimulated by an agonist-activated 
receptor. 
Nucleoside diphosphokinase; G,-protein; Adenylate cyclase; GTP analog; Prostaglandin E,; Platelet membrane 
1. INTRODUCTION 
The hormone-sensitive adenylate cyclase is 
regulated by two distinct guanine nucleotide- 
binding regulatory proteins, Gs and Gi , mediating 
enzyme stimulation and inhibition, respectively. 
Activation of these G-proteins following hormone 
receptor interaction is apparently initiated by the 
dissociation of GDP bound to the a-subunit of G- 
proteins and the subsequent binding of GTP to this 
G-protein component. G-proteins can also be ac- 
tivated by poorly hydrolyzable GTP analogs such 
as GTP[$S] and guanylyl imidodiphosphate, apro- 
cess which is time-dependent and which is ac- 
celerated by the respective receptor agonists. Due 
to their resistance to the G-protein GTPase activi- 
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ty, these analogs can cause persistent activation of 
G-proteins with subsequent persistent stimulation 
(Gs) or inhibition (Gi) of the adenylate cyclase 
[l-5]. 
It has been reported that membrane-associated 
nucleoside diphosphokinase, catalyzing phosphate 
group transfer from ATP to GDP, thereby, leading 
to GTP accumulation, can control the activity of 
the adenylate cyclase regulatory G-proteins GS and 
Gi [6-lo]. Furthermore, a close association of 
nucleoside diphosphokinase with certain G- 
proteins has been reported, possibly leading, 
thereby, to a more specific phosphate group 
transfer to GDP [ll-131. Nucleoside 
diphosphokinase not only transfers a phosphate 
group from ATP to GDP, but this enzyme has also 
been shown to transfer the thiophosphate group 
from ATP[$S] to GDP leading to the formation of 
GTP[yS], by using purified enzyme as well as in 
membranes of HL 60 cells and homogenates of 
bullfrog atrial myocytes [14-161. Therefore, we in- 
vestigated whether such a reaction also occurs in 
membranes of human platelets and whether it is 
regulated by agonist-activated receptors. We report 
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here that human platelet membranes possess 
nucleoside diphosphokinase activity [ 171, which 
can catalyze the formation of GTP[yS] from 
ATP[yS] and GDP, thereby leading to persistent 
Gs-protein and subsequent adenylate cyclase ac- 
tivation, and that this process can be activated by 
the adenylate cyclase stimulatory hormone PGEi . 
2. MATERIALS AND METHODS 
2.1. Materials 
Creatine kinase and unlabeled nucleotides were obtained 
from Boehringer Mannheim (Mannheim); PGEr and creatine 
phosphate from Sigma (Deisenhofen); [I(-‘H]GDP (13.1 
Ci/mmol) from Amersham Buchler (Braunschweig and po- 
ly(ethyleneimine)-cellulose F thin-layer chromatography sheets 
from Merck (Darmstadt). [cr-“P]ATP was prepared en- 
zymatically [ 181. 
2.2. Preincubation of platelet membranes 
Crude membranes of human platelets were prepared as in 1191 
with 5 mM EDTA present during the membrane preparation 
procedure. Platelet membranes (- 5OOr(g) were incubated for 10 
min at 25°C in a total volume of 150 ,ul. The reaction mixture 
contained SO mM triethanolamine-HCl (pH 7.4) and facultative 
additions such as 50pM ATP[rS], 2 mM MgClz, 2/M PGEr or 
5 mM creatine phosphate plus 0.4 mg/ml creatine kinase. The 
reaction was started by addition of ATP[yS] or Hz0 and ter- 
minated by adding 850~1 ice-cold 10 mM triethanolamine-HCl, 
(pH 7.4). The membranes were pelleted by centrifugation for 10 
min at 30 000 x g. The supernatant was discarded and the mem- 
branes were washed twice more with 1 ml ice-cold buffer. The 
final pellet was resuspended in 10 mM triethanolamine-HCI (pH 
7.4) and immediately used for adenylate cyclase assay. 
2.3. Adenylate cyclase assay 
Adenylate cyclase activity was determined in a reaction mix- 
ture containing 50 mM triethanolamine-HCI (pH 7.4), 50 PM 
[CU-‘*P]ATP (0.1 &i/tube), 2 mM MgClz, 0.1 mM EGTA, 0.1 
mM cyclic AMP, 1 mM 3-isobutyl-1-methylxanthine, 1 mM 
dithiothreitol, 5 mM creatine phosphate and 0.4 mg/ml creatine 
kinase in a total volume of 100~1. The reaction was started by 
adding the preincubated and washed human platelet membranes 
(40-5Opg protein/tube) and conducted for 10 min at 30°C. In- 
cubation was terminated and cyclic AMP was isolated as in 1201. 
2.4. Measurement of GTP[ySJ formation 
The assay mixture for measurement of GTP[yS] formation in 
platelet membranes contained, in a total volume of 50 ,ul: 0.5 
pM [“H]GDP (O.ZS,Ki/tube), 50 mM triethanolamine-HCl (pH 
7.4) and facultative additions used at the same concentrations as 
described in section 2.2. Reactions were initiated by the addition 
of human platelet membranes (40-5Opg protein/tube) and con- 
ducted for 10 min at 25°C. For termination of the reaction, ED- 
TA was added to give a final concentration of 17 mM in a total 
volume of 60 ~1. The assay tubes were centrifuged for 3 min at 
88OOxg and the supernatant was analysed for formation of 
[3H]GTP[yS] as described [15]. 
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3. RESULTS 
When human platelet membranes were prein- 
cubated for 10 min at 25°C with the ATP analog 
ATP[$S] (SOpM), subsequently washed and, then, 
studied for adenylate cyclase activity without addi- 
tion of any stimulatory agent, a marked persistent 
stimulation was observed (fig. 1). Without MgClz 
in the preincubation, only weak activation was 
observed. When MgClz (2 mM) was present during 
preincubation, stimulation by ATP[yS] was 
increased 4-fold. In the additional presence of 
GDP (0.3 PM), activation of adenylate cyclase by 
ATP[+] was increased further by 40-50%. When 
the platelet adenylate cyclase stimulatory hormone 
PGEl (2 PM) was included in the preincubation 
medium and subsequently removed by the mem- 
brane washing procedure, the stimulation caused 
by ATP[+] in the presence of MgCL was increas- 
ed further by 3-5-fold. In contrast, when the NTP- 
regenerating system creatine phosphate (5 mM) 
plus creatine kinase (0.4 mg/ml) was present dur- 
ing the preincubation, no effect of ATP[yS] on 
subsequently measured adenylate cyclase activity 
was observed. In the absence of ATP[$S], none of 
the other additions had a major influence on 
adenylate cyclase activity, indicating that the mem- 
brane washing procedure efficiently removed any 
free or loosely bound agent, particularly the 
stimulatory hormone PGEi. In comparison to 
ATP[yS], preincubation of platelet membranes 
with ATP or its analog, adenylyl imidodiphos- 
phate, did not cause adenylate cyclase stimulation 
(not shown). 
These date suggest hat ATP[+] is used by a 
membrane-associated nucleoside diphosphokinase 
to form GTP[yS] leading to persistent adenylate 
cyclase activation. Furthermore, the data obtained 
with creatine phosphate plus creatine kinase sug- 
gested that this treament removed endogenous 
GDP from the membranes, thus preventing the 
formation of GTP[yS]. Therefore, we determined 
whether the stimulatory hormone PGEr can 
counteract this suppressive action of the NTP- 
regenerating system. As shown in fig.2, creatine 
phosphate plus creatine kinase completely sup- 
pressed the adenylate cyclase stimulatory action of 
ATP[$S] under control conditions. However, in 
the additional presence of PGEi (2 PM), the in- 
hibitory effect of the NTP-regenerating system 
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Fig. 1. Regulation of ATP[yS]-induced platelet adenylate 
cyclase stimulation. Human platelet membranes were prein- 
cubated for 10 min at 25°C without (open bars) and with 50pM 
ATP[+] (hatched bars) in the absence (Con) and presence of 2 
mM MgC12 (Mg), MgClr plus 0.3 PM GDP (Mg + GDP), MgC12 
plus 2 ,uM PGEr (Mg+PGEr) or MgClr plus 5 mM creatine 
phosphate plus 0.4 mg/ml creatine kinase (Mg + CP/CK). After 
repeated washing of the membranes, adenylate cyclase activity 
was determined in the absence of a stimulatory agent, as 
described in section 2. 
was, at least partially, reversed, with ATP[yS] 
leading to 45% of adenylate cyclase activity com- 
pared to that observed in the absence of the NTP- 
regenerating system. 
The data presented so far provided only func- 
tional evidence for a nucleoside diphosphokinase- 
mediated formation of GTP[yS] from ATP[yS] 
and GDP. Therefore, the formation of GTP[yS] 
by platelet membranes was measured directly, 
under the same conditions as used for preincuba- 
tion of the platelet membranes. As shown in table 
1, with 0.5 PM [3H]GDP as acceptor substrate, 
ATP[yS] (50pM) led to the formation of 2 pmol 
[3H]GTP[yS] per mg platelet membrane protein 
within 10 min at 25”C, corresponding to a GTP[$S] 
concentration of about 2 nM under the assay con- 
ditions used. This value was apparently not af- 
fected by the presence of the adenylate cyclase 
stimulatory hormone PGEr (2pM). As also found 
in membranes of HL 60 cells [15], the presence of 
creatine phosphate (5 mM) plus creatine kinase (0.4 
mg/ml) almost completely prevented the formation 
of GTP[yS] from GDP and ATP[$]. Most in- 
terestingly, in the additional presence of PGEr, 
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Fig.2. Influence of PGEr on ATP[yS]-induced platelet 
adenylate cyclase stimulation. Human platelet membranes were 
preincubated for 10 min at 25°C without (open bars) and with 
50 FM ATP[rS] (hatched bars) in the absence (Control) and 
presence of 2,uM PGEr (PGEr), 5 mM creatine phosphate plus 
0.4 mg/ml creatine kinase (CP/CK) or a combination of PGEr 
and creatine phosphate plus creatine kinase (CP/CK + PGEI). 
MgCl2 (2 mM) was present under each condition. Washing of 
the membranes and measurement of adenylate cyclase activity 
were performed as in fig. 1. The difference in absolute adenylate 
cyclase activity between fig. 1 and this figure is due to the use of 
different platelet membrane preparations with different basal 
and stimulated activities. 
which counteracted the suppressive action of the 
NTP-regenerating system on ATP[yS]-induced 
adenylate cyclase activation, significant formation 
of [3H]GTP[yS] was again observed, reaching 
about 20% of the value observed in the absence of 
Table 1 
Regulation of GTP[$S] formation in membranes of human 
platelets 
Addition [3H]GTP[$S] formation 
(pm01 . 10 min - ’ . mg protein - ‘) 
Control PGEI 
None 
CP+CK 
1.96i0.14 1.96kO.20 
0.07 f 0.02 0.37 + 0.05 
Formation of [‘H]GTP[rS] in human platelet membranes (50 
fig protein/tube) was measured with 0.5 /rM [‘H]GDP and 50 
/rM ATP[+] as substrates in the absence and presence of 2pM 
PGEr , 5 mM creatine phosphate (CP) plus 0.4 mg/ml creatine 
kinase (CK) or a combination of PGEr and creatine phosphate 
plus creatine kinase. MgCl2 (2 mM) was present under each con- 
dition. Means of triplicate values + SE are given 
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the NTP-regenerating system. In the absence of 
MgClz and/or ATP[yS], formation of [3H]GTP- 
[yS] was not observed (not shown). 
4. DISCUSSION 
The present data indicate that human platelet 
membrane Gs-protein can be persistently activated 
by GTP[$S] locally formed from ATP[yS] and en- 
dogenous GDP by the action of a nucleoside 
diphosphokinase. That the observed adenylate 
cyclase stimulation is not due to ATP[yS] itself or 
to a contamination by GTP[yS] was made unlikely 
by the data obtained with creatine phosphate plus 
creatine kinase. This NTP-regenerating system, ap- 
parently by removing GDP, prevented both the 
adenylate cyclase stimulation by ATP[yS] and the 
formation of GTP[yS] from ATP[+] and GDP. 
The involvement of a nucleoside diphosphokinase 
reaction is, furthermore, strengthened by the 
finding that Mg2+, which is required for nucleoside 
diphosphokinase activity [21], was necessary for 
maximal adenylate cyclase activation by ATP[$S], 
although, on the other hand, the persistent activa- 
tion of G-proteins by GTP[yS] is also known to re- 
quire Mg 2+ 1 [ - 51. Since the stimulatory effect of 
ATP[yS] was only slightly increased by addition of 
GDP, it has to be assumed that the membrane 
preparation used contained enough endogenous 
GDP serving as acceptor for the nucleoside di- 
phosphokinase-dependent conversion to GTP[yS] 
in the presence of ATP[yS]. Furthermore, the data 
obtained with creatine phosphate plus creatine 
kinase, apparently preventing the formation and 
subsequent action of GTP[yS], indicate that the 
endogenous GDP used for the formation of 
GTP[+] is not tightly bound to a membrane- 
associated GDP-binding protein or even only 
loosely associated with the membrane preparation 
and, hence, accessible for the creatine kinase. 
The enhancing effect of PGEi on adenylate 
cyclase stimulation by ATP[yS] can be explained 
by either accelerated binding of the formed 
GTP[yS] to the Gs-protein and/or stimulated for- 
mation of GTP[yS] leading to more pronounced 
Gs-protein activation. In measuring formation of 
GTP[yS] in the absence of creatine phosphate plus 
creatine kinase, no enhancing effect of PGEr was 
observed, suggesting that PGEi may not stimulate 
the formation but only the action of the formed 
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GTP[yS]. With the GTP[yS] extraction procedure 
applied, we may have missed some GTP[yS] form- 
ed, i.e., that fraction which is tightly bound to G- 
proteins and which does not fall off by removing 
Mg2+ with EDTA [5]. However, even by measuring 
this G-protein-bound GTP[yS], it would not be 
possible to discriminate between receptor-stimulat- 
ed formation of GTP[yS] with subsequent binding 
to the G-protein and unaltered formation but 
stimulated binding of the GTP analog to the Gs- 
protein. Therefore, the effect of PGEi on GTP[$S] 
formation was measured in the presence of creatine 
phospate plus creatine kinase, which completely 
suppressed control GTP[yS] formation and subse- 
quent Gs-protein activation. In the presence of this 
NTP-regenerating system, PGEi enhanced or par- 
tially restored the formation of GTP[yS] from 
GDP and ATP[yS] as well as the subsequent GS- 
protein activation. These data indicate that the 
agonist-activated PGEi receptor can stimulate the 
formation of GTP[yS]. This agonist-induced 
stimulation may be due by PGEi either providing a 
GDP pool which is not accessible to creatine kinase 
or by leading to the formation of a complex of 
nucleoside diphosphokinase with the Gs-protein 
[18], liganded with GDP, thereby being accessible 
to the nucleoside diphosphokinase but not to the 
creatine kinase. Thus, irrespective of the exact 
mechanism of action, the data provided herein in- 
dicate that the adenylate cyclase stimulatory hor- 
mone PGEi not only accelerates the binding of 
GTP[yS] to the Gs-protein, but also that this hor- 
mone can increase the formation of GTP[$S] from 
GDP and ATP[yS]. The PGEi stimulation of the 
GTP[yS]-forming reaction suggests that the activa- 
tion of G-proteins via the nucleoside diphosphoki- 
nase pathway is a receptor-controlled event and, 
hence, most probably an integrated part of the 
signal transduction cascade. 
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